Title:
ARYLSULFONAMIDE CCR3 ANTAGONISTS
Document Type and Number:
WIPO Patent Application WO/2010/123960
Kind Code:
A3
Abstract:
Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
More Like This:
| JP2005505496 | Bisaryl derivative |
| WO/2024/004500 | UTILIZATION OF A HIBERNATION-LIKE STATE IN NEUROLOGICAL DISEASES |
| JP5345931 | Pyrimidodiazepinone derivative |
Inventors:
LY TAI WEI (US)
FORRESTER JARED ANDREW (US)
FORRESTER JARED ANDREW (US)
Application Number:
PCT/US2010/031833
Publication Date:
September 09, 2011
Filing Date:
April 21, 2010
Export Citation:
Assignee:
AXIKIN PHARMACEUTICALS INC (US)
LY TAI WEI (US)
FORRESTER JARED ANDREW (US)
LY TAI WEI (US)
FORRESTER JARED ANDREW (US)
International Classes:
A61K31/551; C07D295/26; A61P11/06; A61P25/28
Domestic Patent References:
| WO2003022277A1 | 2003-03-20 |
Attorney, Agent or Firm:
GEORGE, Nikolaos, C. et al. (222 East 41st StreetNew York, NY, US)
Download PDF: